Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.78% is 21% above its 5-year average of 6.41%, near the high end of its 5-year range (4.66%–7.93%).
13.16% above its 12-month average of 6.88%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 2.66%.
RETURN ON ASSETS (ROA)
7.78%
RETURN ON ASSETS (ROA) AVG TTM
6.88%
RETURN ON ASSETS (ROA) AVG 3Y
7.02%
RETURN ON ASSETS (ROA) AVG 5Y
6.41%
RETURN ON ASSETS (ROA) AVG 10Y
7.27%
RETURN ON ASSETS (ROA) AVG 15Y
7.59%
RETURN ON ASSETS (ROA) AVG 20Y
9.02%
CURRENT VS TTM AVG
+13.16%
CURRENT VS 3Y AVG
+10.87%
CURRENT VS 5Y AVG
+21.28%
CURRENT VS 10Y AVG
+7.03%
CURRENT VS 15Y AVG
+2.51%
CURRENT VS 20Y AVG
-13.77%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+51.36%
vs the sector median at left
Stryker Corporation
Market Cap
$108.06B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$106.65B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$120.07B
Return on Assets (ROA)
5.61%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$121.92B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$92.12B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$92.00B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$130.94B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $108.06B | 7.78% | 6.88% | 7.02% | 6.41% |
| McKesson Corporation (MCK)vs › | $106.65B | 5.20% | 5.08% | 5.08% | 2.52% |
| Sanofi (SNY)vs › | $104.04B | 3.12% | 5.18% | 5.31% | 6.19% |
| GSK plc (GSK)vs › | $100.28B | 7.91% | 6.85% | 11.28% | 9.07% |
| Medtronic plc (MDT)vs › | $120.07B | 5.61% | 5.13% | 4.62% | 4.65% |
| CVS Health Corp. (CVS)vs › | $121.92B | 1.93% | 1.25% | 1.93% | 2.38% |
| HCA Healthcare, Inc. (HCA)vs › | $92.12B | 11.30% | 10.43% | 10.23% | 10.42% |
| Elevance Health Inc. (ELV)vs › | $92.00B | 3.93% | 4.89% | 5.25% | 5.41% |
| Bristol-Myers Squibb Company (BMY)vs › | $130.94B | 10.59% | -0.92% | 3.28% | 1.99% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $131.85B | 16.06% | 6.37% | 11.74% | 14.58% |
ROA
7.8%
ROE
15.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 6.78% |
| 2024-12-31 | 6.97% |
| 2023-12-31 | 7.93% |
| 2022-12-31 | 6.39% |
| 2021-12-31 | 5.76% |
| 2020-12-31 | 4.66% |
| 2019-12-31 | 6.90% |
| 2018-12-31 | 13.05% |
| 2017-12-31 | 4.60% |
| 2016-12-31 | 8.06% |
| 2015-12-31 | 8.86% |
| 2014-12-31 | 2.91% |
| 2013-12-31 | 6.39% |
| 2012-12-31 | 9.64% |
| 2011-12-31 | 10.84% |
| 2010-12-31 | 11.69% |
| 2009-12-31 | 12.21% |
| 2008-12-31 | 15.10% |
| 2007-12-31 | 13.83% |
| 2006-12-31 | 13.24% |
| 2005-12-31 | 13.66% |
| 2004-12-31 | 11.40% |
| 2003-12-31 | 14.36% |
| 2002-12-31 | 12.27% |
| 2001-12-31 | 11.02% |
| 2000-12-31 | 9.09% |
| 1999-12-31 | 0.75% |
| 1998-12-31 | 1.37% |
| 1997-12-31 | 12.72% |
| 1996-12-31 | 10.52% |
